AUTONOMOUS THERAPEUTICS INC

Biotech · Private

Encrypted RNA (encRNA) therapeutics—a platform technology for developing antivirals against RNA viruses, with AT191 as a lead SARS-CoV-2 candidate designed for self-administration

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · autonomoustherapeutics.com

Sector: Biotech
Total capital: $9.2M

Federal grants: $4.3M; 3 awards · 2017–2025; Rank in peer group#324 of 514
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: $4.9M; 2 awards · Interior, Defense; Rank in Biotech#80 of 4373
Granted patents: 0; 10 pending

Capital timeline

Latest events

Sep 2025Federal grantHealth and Human S · Phase II · AT191: An inhaled & precision RNA therapeutic with pan-variant SARS-CoV-2 efficacy$1M
May 2024Federal grantHealth and Human S · Phase I · Synthetic RNA sensors to enable high-throughput, quantitative screens for broad-spectrum antivirals$274K
May 2021Federal contractDefense · SBIR Phase II R&d$1.6M
Feb 2020Federal contractInterior · First-in-human Therapeutic Interfering Particle (tip) Targeting A Respiratory Virus$3.2M
Dec 2017Federal grantDefense · Phase II · New Platform Technologies for Viral and Therapeutic Evolution Assays$3M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 514 peers

Line = median

Biotech · Molecule

Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 10

PendingAlphaviral Encrypted Rnas And Their Methods Of UseUSPTOApplication PCTUS2025011215
PendingProgrammable, Rna Editor-controlled Nucleic Acid Dose Amplifiers And Their Methods Of UseUSPTOApplication PCTUS2025011212
PendingEncrypted RNA and Methods of Its UseUSPTOApplication 18992412

Show all 10 patent records

Alphaviral Encrypted Rnas And Their Methods Of UseApplication PCTUS2025011215Pending
Programmable, Rna Editor-controlled Nucleic Acid Dose Amplifiers And Their Methods Of UseApplication PCTUS2025011212Pending
Encrypted RNA and Methods of Its UseApplication 18992412Pending
Programmable, RNA Editor-Controlled Nucleic Acid Dose Amplifiers and Their Methods of UseApplication 63619723Pending
Alphaviral Encrypted RNAS and Their Methods of UseApplication 63619726Pending
Encrypted Rna And Methods Of Its UseApplication PCTUS2023069976Pending
Encrypted Rna And Methods Of Its UseApplication 63493906Pending
Encrypted Rna And Methods Of Its UseApplication 63390245Pending
Encrypted Rna And Methods Of Its UseApplication 63390139Pending
Encrypted Rna And Methods Of Its UseApplication 63388110Pending

Inhalon Biopharma, Inc.Similar federal contract value in Biotech · $5.4M in contracts
CELL MICROSYSTEMS INCSimilar federal contract value in Biotech · $5.1M in contracts
PLATELET BIOGENESIS, INCSimilar federal contract value in Biotech · $5M in contracts
QRONO, INCSimilar federal contract value in Biotech · $4.9M in contracts
SIGMOVIR BIOSYSTEMS, INC.Similar federal contract value in Biotech · $4.9M in contracts
MIMEDX GROUP, INC.Similar federal contract value in Biotech · $4.8M in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.